Neurocrine Biosciences NBIX
NASDAQ NBIX
$154.04 -1.50 (-0.96%)
At close: Aug 20, 2026 · 12:56 PM UTC

Neurocrine Biosciences (NBIX) Net Cash Flow Growth (3y) (2013 - 2026)

Neurocrine Biosciences (NBIX) Net Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (3y) (Qtr)
1 Haleon 43.96 Bn 43.00 Bn - -
2 Teva Pharmaceutical Industries 43.23 Bn 39.58 Bn 2.15 Bn -28.90%
3 Zoetis 31.76 Bn 30.08 Bn 1.05 Bn -5.41%
4 Takeda Pharmaceutical 28.68 Bn 22.88 Bn 5.10 Bn 19.55%
5 United Therapeutics 22.27 Bn 19.61 Bn 683.80 Mn 95.24%
6 Viatris 18.69 Bn 17.81 Bn 1.46 Bn -106.21%
7 Neurocrine Biosciences 15.56 Bn 15.17 Bn 935.80 Mn 4.40%
8 Elanco Animal Health 11.78 Bn 11.25 Bn 798.00 Mn 17.73%
9 Dr Reddys Laboratories 10.13 Bn 9.97 Bn - -
10 Alkermes 8.14 Bn 7.48 Bn 397.90 Mn -22.55%

Historic Data

Download Data
DateValue
Jun 30, 2026 4.40%
Mar 31, 2026 -41.05%
Dec 31, 2025 92.82%
Sep 30, 2025 16.04%
Jun 30, 2025 38.42%
Mar 31, 2025 16.16%
Dec 31, 2024 -80.69%
Sep 30, 2024 78.37%
Jun 30, 2024 -165.25%
Mar 31, 2024 -4.27%
Dec 31, 2023 43.53%
Sep 30, 2023 135.66%
Jun 30, 2023 -37.16%
Mar 31, 2023 -60.44%
Dec 31, 2022 42.99%
Sep 30, 2022 24.57%
Jun 30, 2022 -52.80%
Mar 31, 2022 1.42%
Dec 31, 2021 36.62%
Sep 30, 2021 -57.96%